Life Extension Ventures

Inaki Berenguer and Amol Sarva serve as Co-Founders and Managing Partners. Both have operational backgrounds as repeat tech founders — Berenguer built and exited CoverWallet to Aon, while Sarva co-founded Knotel and Halo Neuroscience. Investment decisions appear concentrated with the two partners, who take board seats in portfolio companies.

The firm relies on a network of scientific advisors and academic partnerships, particularly at universities with strong biology, AI, and environmental science programs. Berenguer and Sarva have cited their direct relationships with researchers as a primary source of pre-institutional deal flow. This academic pipeline differentiates the firm from more network-driven early-stage investors.

Life Extension Ventures invests directly in seed and pre-seed companies and does not publicly report making fund-of-fund commitments. Its model is to lead or co-lead early rounds and maintain active board involvement rather than deploying capital through other GPs.

The firm focuses on pre-seed and seed-stage companies, occasionally participating in Series A rounds for existing portfolio companies. Its thesis prioritizes early entry into science-heavy startups where technical risk is high but the potential time horizon to value creation is measured in decades rather than quarters.

Unlike funds that separate human longevity from climate or planetary health into distinct vehicles, Life Extension Ventures treats them as a single thesis. The partners argue that extending healthy human life is inseparable from restoring planetary systems — a combined mandate that structures their portfolio across biotech, climate monitoring, and environmental AI.